AtaiBeckley Share Price
NASDAQ: ATAI | Healthcare$0.00
+0.00 (0.00%) AtaiBeckley Stock Performance
AtaiBeckley Share Price Chart
$0.00$0.00
L
H
Corporate Actions
About AtaiBeckley
AtaiBeckley Inc is a clinical-stage biopharmaceutical company on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments. AtaiBeckley's pipeline of novel therapies includes BPL-003 (mebufotenin benzoate nasal spray) for treatment-resistant depression (TRD), VLS-01 (DMT buccal film) for TRD, and EMP-01 ((R)-MDMA HCI) for social anxiety disorder, which are in Phase 2 clinical development.
AtaiBeckley Historical Returns
| Month | Open | Close | Change % |
|---|